S C Kelly
Overview
Explore the profile of S C Kelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly S, ORourke M
Proc Inst Mech Eng H
. 2010 Oct;
224(8):955-69.
PMID: 20923114
This work reports on the implementation and validation of a two-system, single-analysis, fluid-structure interaction (FSI) technique that uses the finite volume (FV) method for performing simulations on abdominal aortic aneurysm...
2.
Buch A, Shen L, Kelly S, Russell D, Sahota R, Bixler C, et al.
Climacteric
. 2002 Mar;
2(4):248-53.
PMID: 11910658
Objective: To compare the bioavailabilities of estradiol delivered by two transdermal estradiol matrix systems; Alora and Evorel. Study Design: A single-center, open-label, randomized, two-period cross-over study in 33 postmenopausal women....
3.
Mitchell D, St Peter J, Eusebio R, Pallone K, Kelly S, Russell D, et al.
Br J Clin Pharmacol
. 2000 Mar;
49(3):215-22.
PMID: 10718776
Aims: To determine the relationship between risedronate pharmacokinetics and renal function. Methods: Risedronate was administered to adult men and women (n=21) with various degrees of renal function (creatinine clearance 15-126...
4.
Mitchell D, Eusebio R, Pallone K, Kelly S, Nesbitt J, Brezovic C, et al.
J Clin Pharmacol
. 2000 Mar;
40(3):258-65.
PMID: 10709154
Risedronate is a pyridinyl bisphosphonate approved for the treatment of Paget's disease (US-FDA) and in development for the treatment and prevention of osteoporosis. This study examined risedronate pharmacokinetics and tolerability...